- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00795405
Cardiovascular Effects of Sporting Events
Cardiovascular Effects of Major Sporting Events in Subjects With Coronary Heart Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Observational studies suggest that exposure to sporting events may worsen symptoms of angina and trigger acute myocardial infarction. The mechanisms for this association are unknown. To date, there have been no controlled exposures in patients with coronary heart disease: an important population who may be particularly susceptible to the adverse cardiovascular effects of sporting events.
In a randomized crossover controlled study, 38 patients with prior myocardial infarction will be exposed to sporting events or not. Myocardial ischemia will be quantified by ST-segment analysis using continuous 12-lead electrocardiography, and blood pressure change will be analyzed using ambulatory blood pressure monitoring. Autonomic function will be assessed by heart rate variability. Ischemic, inflammatory and prothrombotic markers will also be measured.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Previous myocardial infarction (>6 months previously)treated by coronary revascularization
- On standard secondary preventative therapy
Exclusion Criteria:
- Angina pectoris (Canadian Cardiovascular Society grade ≥2)
- History of arrhythmia
- Uncontrolled hypertension
- Unstable coronary disease (acute coronary syndrome or unstable symptoms within 3 months)
- Occupational exposure to sporting events
- Diabetes
- Hepatic or renal failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: 1
No exposure to sporting events
|
No exposure to sporting events
|
|
Experimental: 2
Exposure to sporting events
|
Exposure to sporting events
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evidence of definite myocardial ischemia confirmed by Holter monitoring
Time Frame: 2 months
|
2 months
|
|
Blood pressure measured by ambulatory blood pressure monitoring
Time Frame: 2 months
|
2 months
|
|
Heart rate variability
Time Frame: 2 months
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Episode of angina
Time Frame: 3 months
|
3 months
|
|
Episode of neurological events
Time Frame: 3 months
|
3 months
|
|
Episode of arrhythmia
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Shengshou Hu, MD, Cardiovascular Institue and Fuwai Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- sporting events
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.